SON: the bull case, the bear case, and the verdict
Why the screener flagged it
- Low PEG ratio
- Revenue growth accelerating
- Bollinger Band squeeze breakout
The bull case
Opening argument: the bear is missing the forest for the trees
Listen, I appreciate the thoroughness of the bear's analysis, but I think we're looking at fundamentally different risk/reward profiles here. The bear is correctly identifying risks that are already priced into the stock. That's the whole point—when a stock trading at 7.9x P/E and with a PEG ratio of 0.21 trades below normalized earnings, the market has already discounted most of the bad news. Let me make the bull case clearly:
1. Valuation is the anchor—and it's compelling
The Numbers Don't Lie
The bear acknowledges SON trades at 7.9x P/E vs. industry average of 12-14x. Let's pause and digest what that means:
- Normalized earnings (ex one-time items): ~$2.80-3.00 per share annually
- Forward normalized EPS (conservative): $6.50-7.00
- Industry standard P/E multiple: 12-14x
- Fair value calculation: $6.50 × 12.5x = $81.25 per share
The stock is trading at $51—that's a 37% discount to fair value using conservative industry multiples.
Now, here's where I push back on the bear: Yes, the company has leverage and revenue headwinds. But those factors are already reflected in the valuation discount. The bear can't simultaneously argue that:
- The company is fundamentally broken (requires massive P/E compression to distressed levels like 5-7x), AND
- The company is merely "stressed" with solid operations (which would support 10-12x P/E)
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The bear case
Opening salvo: the bull is pricing a perfect recovery that rarely materializes
I respect the bull's passion, but I need to be direct: the bull is constructing a recovery narrative that depends on multiple simultaneous assumptions all being correct. That's not investing—that's wishful thinking masquerading as analysis. Let me systematically dismantle this thesis point by point.
The bull's central argument boils down to: "The stock is cheap, so buy it and wait for multiple expansion." But cheap stocks are cheap for a reason. And that reason isn't always temporary—sometimes it's because the market has correctly identified deteriorating fundamentals that won't reverse.
1. The "valuation floor" argument is built on normalizing earnings that don't exist
The Bull's Fair Value Math Doesn't Hold Up Under Scrutiny
The bull claims normalized EPS of $6.50-7.00 justified by applying 12-14x multiples to arrive at $72-87 fair value. But here's the critical flaw: those "normalized" earnings are a fiction.
Let me break down what actually happened:
Reported EPS (TTM): $10.07 (heavily inflated by $305.5M one-time gain in 2025)
Adjusted for one-time items
- Remove $305.5M unusual gain (Q2 2025)
- This reduces TTM earnings by ~$3.06 per share
- True normalized TTM EPS: ~$7.01
But wait—that's still using 2025 data, which included inflated revenue from M&A.
Looking at underlying quarterly performance (2026)
- Q1 2026: $0.68 EPS
- Q2 2026: $1.05 EPS
- Run-rate: ~$2.76 annually
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The research manager's call
Recommendation: Underweight
Rationale: This was a vigorous debate with genuinely strong arguments on both sides, but on balance the bear carried the more structurally sound points, even if their $32–38 target feels too aggressive. Here's how I weigh the key battlegrounds:
Where the Bull Won
The bull is absolutely right that SON's stated 7.9x P/E looks optically cheap, that the company generated real cash in 2025, and that institutional buyers and insiders have been adding exposure. The deleveraging trajectory from 2024 to 2025 is also factually accurate, and the technical setup (RSI recovery from oversold, MACD inflection) is a legitimate near-term constructive signal. The dividend coverage of 2.6x on 2025 FCF is real.
Where the Bear Won — and Why It Tips the Scales
- Earnings quality is the critical flaw in the bull case. The bull anchors to $6.50–7.00 normalized EPS, but the actual 2026 run-rate is roughly $2.76 per share ($0.68 + $1.05 annualized). The bull's "normalized" figure relies heavily on a year (2025) inflated by $305M in one-time gains and M&A revenue. The bear's deconstruction of this is largely correct, and it fundamentally undermines the 37%-discount-to-fair-value argument.
- The deleveraging story is asset-sale driven, not operationally driven. The bear correctly identifies that the ~$2.6B debt reduction between 2024 and 2025 was funded primarily by $2.2B in business sale proceeds. In 2026, debt has actually ticked back up ($4.59B → $4.71B). If revenue continues declining and EBITDA compresses toward $1.2B, the Debt/EBITDA ratio likely rises toward 3.9x rather than falling to the bull's promised 2.5x. This is a meaningful risk.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
Stress-test your own thesis on SON (or any US stock)
Enter a ticker, your optional thesis, and your email. Twelve AI analysts will argue the bull and bear case, test your reasoning, and email your 4-page PDF report.
Unlock the full trade plan & Trader desk
Stop loss and take profit levels, position sizing, the risk team's debate and the full transcript for SON are in Pro ($39/mo or $379/yr, 5/day). Or upgrade to Trader ($99/mo or $949/yr, 10/day) for live position tracking vs the S&P 500, price/stop email alerts, weekly Monday AI thesis re-checks, and an Alpaca paper-trading order ticket.
Get Pro — $39/mo →Get Trader — $99/mo →5-Report Pack — $19 one-time →Founding Lifetime Pass — $499 (20 seats) →Other recent analyses
This page was generated automatically by HedgePick's AI agents from public market data. It is general information, not personalized investment advice, and not a recommendation to buy or sell any security. AI output can be wrong or out of date. HedgePick is not a registered investment adviser or broker-dealer. Do your own research and consider your own situation before trading.